Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.60% to 9136.32, DAX +1.03% to 24217.37, CAC40 +0.72% to 7857.36, STOXX 600 +0.33% to 550.58

Jul 29 ,2025

  • Synopsis:

    • European equity markets ended mostly higher, although pan-European gape up earlier gains and closed near the session's lowest levels. Italy +1.5%, Greece +1.3% and Germany +1.0% led the outperformers. Denmark fell to ~ (11%), was the outlier to the downside.

    • In geopolitical developments, US and China to resume negotiations on Tuesday after officials left first day of talks without speaking to reporters. Commerce Secretary Lutnick said 90-day extension of US-China tariff deadline is likely outcome of talks, adding weight to SCMP article that first reported details of an extension. Nothing particularly incremental in other trade talks. Officials still working on deal with South Korea and India. Japan working on monitoring framework for implementation of US deal. Elsewhere, Trump gave Russia 10 to 12 days to move on a ceasefire with Ukraine or face secondary sanctions in comment made in his UK visit on Monday..

    • From a macro perspective, ECB consumer expectations survey showed no change in inflation or growth outlook. Spanish GDP firmer than forecast. BoE mortgage lending data on the agenda. Data from BRC and NielsenIQ showed rising UK food prices boosted shop price inflation in July.

    • In corporate news, Koninklijke Philips (PHIA.NA) traded notable higher following strong Q2 earnings and raised full-year guidance, increasing core profit margin forecast to 11.3%-11.8%. In the DACH region, Redcare Pharmacy (RDC.GR) Q2 adjusted EBITDA surpassed expectations, TeamViewer (TMV.GR) posted Q2 numbers with revenue up 16.2% y/y and Adjusted EBITDA at €84M, beating consensus by 4% and margin expanding to 44%. Sika Group (SIKA.SW) posted H1 numbers with net income of CHF 554.4M, missing expectations. SÜSS MicroTec (SMHN.SW) cut its FY outlook due to extraordinary costs and inventory corrections. From the Nordics, Novo Nordisk (NOVO.B.DC) shares plunged following its Q2 earnings and lowered FY guidance.

    • In the UK, Barclays (BARC.LN) posted better-than-expected Q2 and announced intention to initiate up to £1B buyback. AstraZeneca (AZN.LN) posted in-line Q2 core operating profit and reiterated FY25 guidance. Entain (ENT.LN) reported strong BetMGM H1, while Croda International (CRDA.LN) reported weaker -than-expected H1 Adj. Operating Profit at £146.9M vs consensus £149.0M and maintained FY outlook.

    • On M&A front, ams-OSRAM (AMS.SW) announced sale of Entertainment and Industry Lamps (ENI) business to Ushio for €114M. Media reported HSBC (HSBA.LN) hired Citi for sale of Australian retail banking arm, with process set to be launched within weeks.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Banks +1.62%, Telecom +1.60%, Ind Goods & Svcs +1.04%, Insurance +0.95%, Oil & Gas +0.75%, Construct & Mtls +0.64%, Technology +0.47%, Financial Svcs +0.42%

      • Underperformers

        • Health Care (1.58%), Basic Resources (1.14%), Retail (0.93%), Chemicals (0.64%), Real Estate(0.53%), Media (0.49%), Autos & Parts (0.16%), Persnl & HHold Goods (0.08%), Utilities (0.05%), Travel & Leisure +0.01%, Food & Beverage +0.19%

    • Macro/Peripheral markets:

      • Geopolitics

        • EU leaders champion trade deal as predictable despite backlash (Bloomberg)

        • Experts dismiss EU's $750B energy pledge as unrealistic (FT)

        • Germany, France slam EU-US deal as costly to Europe (FT)

        • Trump, Starmer affirm UK-US ties as "special relationship" (Reuters)

        • Trump's EU arms sales boast doesn't add up (Politico )

      • EU

        • EU transport chief warns infrastructure unfit for war with Russia (FT)

        • EU and US spin conflicting versions of trade deal, sowing confusion (Euronews )

      • ECB

        • ECB staff blast Lagarde for undemocratic governance (FT)

      • UK

        • UK retailers warn food price inflation strains budgets (YahooFinance, Reuters)

        • UK MPs push gambling tax hike to curb harmful betting (FT)

        • BoE's Bailey blocks Reeves' Revolut meeting as "interference" (FT)

      • France

        • French seek US tariff exemption for champagne and other drinks (FT)

      • Greece

    • Company news:

      • Notable Gainers

        • +38.1% HDD.GR (Heidelberger Druckmaschinen €1.78, +0.60) -- enters into a strategic partnership with VINCORION Advanced Systems GmbH

        • +14.9% RLF.SW (RELIEF THERAPEUTICS Holding CHF3.05, +0.35) -- executes binding term sheet for proposed combination with NeuroX at equity value of CHF100M

        • +11.3% FORT.LN (Forterra Plc £1.99, +0.21) -- H1 earnings

        • +9.6% PHIA.NA (Koninklijke Philips €24.11, +2.12) -- Q2 earnings; increases FY25 adj EBITA margin guidance range by 50 bps

        • +8.5% HEIJM.NA (Heijmans €55.60, +4.40) -- Oddo upgrade

        • +7.9% UNI.SM (Unicaja Banco €2.23, +0.17) -- H1 earnings

        • +7.1% CARD.LN (Card Factory £0.96, +0.06) -- trading update; WH Smith to sell funkypigeon.com to company for £24M in cash

        • +6.2% EL.FP (EssilorLuxottica €258.90, +15.20) -- H1 earnings

        • +6.1% TFI.FP (TF1 €8.36, +0.50) -- Q2 earnings

        • +6.0% IDEX.NO (IDEX Biometrics NOK3.56, +0.20) -- first official technology partner agreement with Savyint Group

        • +5.7% TMV.GR (TeamViewer €9.51, +0.52) -- Q2 earnings

        • +5.4% GAW.LN (Games Workshop Group £155.50, +8.20) -- FY earnings

        • +5.4% IVG.IM (Iveco Group €0.00, +0.98) -- engaged in ongoing, advanced discussions with different parties for potential transactions involving its defence business

        • +4.3% BPE.IM (BPER Banca €8.24, +0.35) -- announces final result of the reopening of the offer for Banca Popolare di Sondrio; resumed outperform at Mediobanca

        • +4.0% FARN.LN (Faron Pharmaceuticals £1.88, +0.08) -- Inderes upgrade

        • +3.7% ELG.GR (Elmos Semiconductor €93.90, +3.30) -- PT increased at Berenberg

        • +3.4% RENX.LN (Renalytix £0.08, -0.00) -- contract

        • +3.4% MGNS.LN (Morgan Sindall Group £45.70, +1.50) -- H1 earnings

        • +2.9% UPR.ID (Uniphar €3.89, +0.11) -- trading update

        • +2.8% NDX1.GR (Nordex €20.88, +0.56)

        • +2.5% EKF.LN (EKF Diagnostics Holdings £0.28, +0.01)

        • +1.8% SAF.FP (Safran €280.30, +4.90)

        • +1.2% IPH.FP (Innate Pharma €2.00, +0.02)

      • Notable Decliners

        • -23.1% NOVO.B.DC (Novo Nordisk DKK0.00, -104.25) -- Q2 earnings; appoints Maziar Mike Doustdar as president and CEO

        • -21.1% TOBII.SS (Tobii SEK5.20, -1.27) -- Q2 earnings

        • -20.6% SMHN.GR (SÜSS MicroTec €33.86, -8.36) -- prelim H1 earnings; adjusts FY margin guidance; Deutsche Bank downgrade

        • -16.6% IGR.LN (IG Design Group £0.67, -0.13) -- FY earnings

        • -15.0% LEHN.SW (LEM Holding CHF860.00, -135.00) -- Q1 earnings

        • -12.9% BFIT.NA (Basic-Fit €23.34, -3.46) -- H1 earnings

        • -12.3% FORN.SW (Forbo Holding CHF780.00, -110.00) -- H1 earnings

        • -11.9% STAF.LN (Staffline Group £0.46, -0.06) -- H1 earnings

        • -10.7% INCH.LN (Inchcape £7.48, -0.86) -- H1 earnings

        • -10.1% XVIVO.SS (Xvivo Perfusion SEK201.20, -22.30) -- announces delay in CE approval for heart perfusion solution and supplement

        • -9.0% EKI.FP (Ekinops €4.04, -0.38) -- H1 earnings

        • -7.9% AMUN.FP (Amundi €67.20, -5.55) -- Q2 earnings

        • -7.9% PAG.LN (Paragon Banking Group £8.88, -0.75) -- trading update; Shore Capital Stockbrokers downgrade

        • -7.5% KOA.NO (Kongsberg Automotive NOK1.66, -0.13) -- ABG Sundal Collier downgrade

        • -7.1% PSG.SM (Prosegur Compania de Seguridad €2.80, -0.21) -- H1 earnings

        • -6.4% METSB.FH (Metsa Board €3.32, -0.21) -- reduce at Inderes downgrade

        • -5.6% SSPG.LN (SSP Group £1.76, -0.10) -- trading update

        • -5.6% BRE.IM (Brembo €0.00, -0.50) -- Q2 earnings

        • -5.2% GRG.LN (Greggs £16.10, -0.85) -- H1 earnings

        • -4.4% PAL.AV (Palfinger €36.45, -1.65) -- laces 2.8M treasury shares at €35.40/share; Hauck & Aufhäuser downgrade

        • -4.2% JHD.LN (James Halstead £1.49, -0.06) -- trading update

        • -3.6% BIRG.ID (Bank of Ireland Group €12.05, -0.45) -- H1 earnings

        • -3.4% SIKA.SW (Sika Group CHF198.35, -7.10) -- H1 earnings

        • -3.2% CLNX.SM (Cellnex Telecom €31.52, -1.02) -- JPMorgan downgrade

        • -3.0% BIOVIC.B.SS (Biovica International SEK0.65, -0.02)

        • -2.7% SAFH00.GR (SAF-HOLLAND €0.00, -0.46) -- prelim H1 earnings

        • -2.0% CTT.PL (CTT - Correios de Portugal €7.27, -0.15) -- Q2 earnings

        • -1.6% ELE.SM (Endesa €24.75, -0.41) -- H1 earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: Raiffeisen Bank International (RBI.AV)

        • Belgium: Solvay (SOLB.BB), Aedifica (AED.BB), Melexis (MELE.BB)

        • Finland: Sanoma (SANOMA.FH)

        • France: Hermes (RMS.FP), Airbus (AIR.FP), VINCI (DG.FP), Danone (BN.FP), Capgemini (CAP.FP), Aeroport de Paris (ADP.FP), Klepierre (LI.FP), Elis (ELIS.FP), La Francaise des Jeux (FDJU.FP), Nexans (NEX.FP), Wendel (MF.FP), Tikehau Capital (TKO.FP), Bic (BB.FP), Eramet (ERA.FP), Worldline (WLN.FP), Manitou BF (MTU.FP), NRJ Group (NRG.FP), Casino Guichard-Perrachon (CO.FP), Deezer (DEEZR.FP), Vantiva (VANTI.FP), SRP Groupe (SRP.FP)

        • Germany: Siemens Healthineers (SHL.GR), Mercedes-Benz Group (MBG.GR), BASF (BAS.GR), Adidas (ADS.GR), Porsche (P911.GR), Symrise (SY1.GR), Kion Group (KGX.GR), Auto1 Group (AG1.AV), Krones (KRN.GR), AlzChem Group (ACT.GR), Befesa (BFSA.GR), KSB (KSB.GR), Amadeus FiRe (AAD.GR)

        • Greece: Piraeus Financial Holdings (TPEIR.GA), Metlen Energy & Metals (MYTIL.GA)

        • Italy: Intesa Sanpaolo (ISP.IM), Leonardo (LDO.IM), Snam (SRG.IM), FinecoBank (FBK.IM), Recordati (REC.IM), Nexi (NEXI.IM), Lottomatica Group (LTMC.IM), Hera (HER.IM), Fincantieri (FCT.IM), Iveco Group (IVG.IM), Iren (IRE.IM), Italmobiliare (ITM.IM), Alerion Cleanpower (ARN.IM), Acinque (AC5.IM), Geox (GEO.IM), Elica (ELC.IM)

        • Netherlands: Wolters Kluwer (WKL.NA), JDE Peet's (JDEP.NA), IMCD (IMCD.NA), Royal Vopak (VPK.NA), AMG Critical Materials (AMG.NA), Just Eat Takeaway.com (TKWY.NA)

        • Norway: PhotoCure (PHO.NO)

        • Other: Kerry Group (KRZ.ID), Arion Banki (ARION.IR)

        • Portugal: Banco Comercial Portugues (BCP.PL), Sonae (SON.PL)

        • Spain: Banco Santander (SAN.SM), Telefonica (TEF.SM), CaixaBank (CABK.SM), Aena S.M.E. (AENA.SM), ACS (ACS.SM), Redeia Corporacion (RED.SM), Viscofan (VIS.SM), Melia Hotels International (MEL.SM), Cox ABG Group (COXG.SM), Vocento (VOC.SM)

        • Sweden: Securitas (SECU.B.SS), Hacksaw (HACK.SS)

        • Switzerland: UBS Group (UBSG.SW), Bucher Industries (BUCN.SW), Inficon Holding (IFCN.SW), Autoneum Holding (AUTN.SW), Idorsia (IDIA.SW)

        • UK: HSBC Holdings (HSBA.LN), BAE Systems (BA.LN), GSK (GSK.LN), Taylor Wimpey (TW.LN), Aberdeen Group (ABDN.LN), Man Group (EMG.LN), Rathbones Group (RAT.LN), RHI Magnesita (RHIM.LN), SEPLAT Energy (SEPL.LN), Bodycote (BOY.LN), Aston Martin Lagonda Global Holdings (AML.LN), Conduit Holdings (CRE.LN), International Personal Finance (IPF.LN), Franchise Brands (FRAN.LN), Hargreaves Services (HSP.LN), Foxtons Group (FOXT.LN), Hostelworld Group (HSW.LN), SDI Group (SDI.LN)

  • Data:

    • Economics:

      • Finland Q2 Preliminary GDP +0.5% y/y vs consensus +0.9% and prior +0.8%

      • Norway Jun Retail Sales 0.0% m/m vs consensus +0.4% and prior revised +0.1% from 0.0%

      • Sweden Q2 Preliminary GDP +0.9% y/y vs consensus +1.7% and prior +0.9%

      • Spain

        • Q2 Preliminary GDP +2.8% y/y vs consensus +2.6% and prior +2.8%

        • Jun Retail Sales +6.2% y/y vs consensus +3.4% and prior revised +5.0% from +4.8%

    • Markets:

      • WTI Crude (Sep 25): +$0.80 or +1.20% to $67.51

      • €-$ (0.0058) or (0.50%) to 1.1531

      • £-$ (0.0018) or (0.14%) to 1.3337

      • €-£ (0.0031) to 0.8646

      • S&P 500 (0.23%)

        • Performance year-to-date

        • FTSE 100: +11.79%

        • DAX: +21.64%

        • CAC: +6.46%

        • MIB: +20.62%

        • Stoxx 600: +8.46%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE